Add Row

Add Element

update

BUSINESS BROKER NEWS

update

Add Element

SUBSCRIBE TO NEWSLETTER

update
update
update
update
update
update
update

January 15.2026

2 Minutes Read

What Business Brokers Need to Know About the 2026 HSR Increase

Name: RP Design Web Services
Address: Cheshire, CT, 06410
Telephone: +12032717991

Understanding the 2026 HSR Threshold Changes

The Federal Trade Commission (FTC) has announced increased jurisdictional thresholds and updated filing fees under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. Effective 30 days post-publication in the Federal Register, the size-of-transaction threshold rises from $126.4 million to $133.9 million, a necessary adjustment to reflect inflation and the growing economy. The HSR Act mandates these updates annually based on changes in the gross national product (GNP) and the consumer price index.

What This Means for Business Brokers

For business brokers, these changes can significantly impact deal assessments. Transactions exceeding the new threshold will require the requisite filings with both the FTC and the Department of Justice (DOJ). A transaction's acceptance under the reporting requirement hinges not only on its value but also on the sales and asset thresholds of the entities involved. Transactions valued between $133.9 million and $535.5 million must meet specific “size-of-person” conditions, which stipulate that at least one parent entity should have sales or assets of approximately $267.8 million.

Filing Fees Adjustments: What You Need to Know

The adjustments also include alterations to the HSR filing fees. The fees are gateway costs that can validate or invalidate a transaction. For instance, the minimum filing fee has increased from $30,000 to $35,000, affecting transactions valued below $189.6 million. For larger deals, the maximum fee stands at $2.46 million for transactions exceeding $5.869 billion. Such fee structures reinforce the necessity for brokers and businesses to consult legal guidance continually, ensuring compliance with antitrust regulations.

Compliance is Key: Avoiding Penalties

Failure to comply with these requirements can lead to severe penalties, with daily fines for non-compliance reaching over $53,000. Business brokers must actively stay informed about these changes to provide accurate advice to their clients, maintaining vigilance against the intricate landscape of antitrust laws.

Conclusion

The 2026 adjustments to the HSR thresholds and filing fees not only reflect economic realities but also challenge brokers to refine their navigation of merger and acquisition environments. As these thresholds shift, so too do the strategies businesses must adopt to ensure compliance and effectively manage their transactions. For brokers, understanding these changes is paramount to guiding clients through the complexities of the modern market.

Legal Updates

1 Views

0 Comments

Write A Comment

Related Posts All Posts

06.12.2025

FTC and DOJ Host Listening Sessions to Reduce U.S. Drug Prices

Update Listening Sessions Aimed at Lowering Drug Prices In a commendable move towards addressing the growing concerns over drug pricing, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) are set to host a series of listening sessions. These sessions aim to explore ways to increase competition in the pharmaceutical industry, thereby lowering prescription drug costs for Americans. As mandated by President Biden's Executive Order, these discussions are critical in fostering an environment where accessibility to medications is prioritized. The Importance of Competition One of the main objectives of the listening sessions is to enhance the availability of generic and biosimilar drugs. By encouraging competition, the hope is to create a more equitable landscape for consumers while also streamlining the prescription drug formularies and benefits. This proactive approach aligns with the growing consensus among healthcare professionals about the necessity for more affordable healthcare solutions. Challenges and Opportunities While the intention behind these sessions is commendable, several barriers exist in realizing their goals. Anticompetitive practices within the pharmaceutical sector have long been a point of contention, including patent abuses and marketing strategies that hinder market entry for generic drugs. Addressing these challenges through stakeholder engagement can foster a more robust and transparent pharmaceutical market. What This Means for Business Brokers As business brokers, understanding the dynamics of the pharmaceutical industry, including the impact of potential regulatory changes, is crucial. The listening sessions represent an opportunity not only to enhance your knowledge but also to recognize market trends that could influence pharmaceutical business transactions. Keeping an ear to the ground on such developments could greatly enhance the value offered to clients. Conclusion: Engage in the Discussion The FTC and DOJ's initiative to hold listening sessions on lowering drug prices through competition is a pivotal step toward more affordable healthcare. As business brokers, staying informed on these discussions will equip you with insights necessary for advising clients in the evolving pharmaceutical landscape. Engage in these conversations and advocate for changes that empower consumers.

06.11.2025

Evoke Wellness Settles for $1.9 Million Over Misleading Ads in Addiction Treatment

Update Deceptive Practices in Substance Use Treatment Advertising The Federal Trade Commission (FTC) has made headlines with its recent order for Evoke Wellness to pay $1.9 million, cementing a pivotal moment in consumer protection law. Located in Florida, Evoke Wellness, along with its management, faced allegations of employing unscrupulous tactics to lure vulnerable individuals searching for substance use disorder treatment. Utilizing deceptive Google ads and telemarketing strategies that presented them as legitimate treatment providers, Evoke misled countless consumers in their hour of need. Targeting the Most Vulnerable: Operational Tactics According to the FTC's complaint, Evoke Wellness disguised itself by utilizing the names of reputable treatment clinics as keywords in their targeted advertising campaigns. This led potential clients to unintentionally reach out to Evoke rather than their intended clinics. Furthermore, once a consumer initiated contact, Evoke's telemarketers misrepresented themselves as part of a centralized admissions office, rather than revealing their true affiliation. The use of such misleading tactics raises ethical questions about the marketing strategies used in health services. Facets of Consumer Protection Law in Action This case serves as an important reminder of the FTC’s unwavering commitment to maintaining transparency and integrity in consumer services, especially in sectors like healthcare. The commission’s action not only holds Evoke accountable but sets a precedent for other companies in the field, emphasizing adherence to ethical marketing practices. Implications for Business Brokers in Healthcare The implications for business brokers focusing on healthcare acquisitions are multifaceted. Ethical compliance in marketing strategy will be crucial for maintaining the integrity of potential investment opportunities. Moreover, brokers must conduct due diligence on the marketing strategies of clinics and ensure practices align with FTC regulations. As consumer protection laws become increasingly scrutinized, it will be vital for brokers to ensure transparency and ethical practices in their dealings. Looking Forward: The Future of Ethical Marketing As this case unfolds, it is expected that the FTC will ramp up efforts in monitoring deceptive practices across the healthcare sector. For business brokers, this serves as both a warning and an opportunity to reassess operational strategies that adhere to ethical guidelines. Brokers should be prepared to navigate an evolving landscape that demands accountability, transparency, and a commitment to ethical standards in marketing. This landmark case and its impacts reinforce the necessity for ongoing vigilance in marketing practices across industries, particularly in sensitive sectors such as healthcare.

06.10.2025

Understanding the FTC's Workshop on Gender-Affirming Care and Its Implications

Update Understanding the FTC's Initiative on Gender-Affirming Care The Federal Trade Commission (FTC) is set to host a workshop titled "The Dangers of ‘Gender-Affirming Care’ for Minors" on July 9, 2025, focused on potential unfair or deceptive trade practices within the realm of gender-affirming care for minors. This initiative has stemmed from a broader political context, particularly following recent executive directives aimed at limiting governmental support for such medical practices. A Gathering of Perspectives This workshop promises to offer a varied array of insights, featuring presentations from a diverse group including medical professionals, ethicists, whistleblowers, detransitioners, and their parents. Each participant will contribute perspectives shaped by substantial research and personal experiences, providing a multifaceted overview that is essential for understanding this contentious topic. The Implications of the Executive Order Triggered by an executive order from President Trump, which critiques the alleged harms stemming from gender-affirming practices, the forthcoming workshop could serve as a crucial platform for discussing consumer protection laws under the Federal Trade Commission Act. This act equips the FTC with the power to regulate practices deemed unfair or deceptive, an issue that many feel needs urgent attention in today’s market. Why This Matters for Business Brokers For business brokers, the discourse surrounding gender-affirming care may seem tangential. However, engaging with the legal frameworks and consumer protections being discussed can directly impact the operations of healthcare ventures and businesses associated with such treatments. Understanding the regulatory landscape is vital for successfully navigating potential pitfalls in this evolving sector. As discussions about gender-affirming care intensify, it is important for professionals in related fields to stay informed about regulatory changes and consumer sentiment. Workshops and initiatives like this provide a wealth of knowledge that can be pivotal for strategic decision-making in healthcare-related businesses.

What Business Brokers Need to Know About the 2026 HSR Increase

Understanding the 2026 HSR Threshold Changes

What This Means for Business Brokers

Filing Fees Adjustments: What You Need to Know

Compliance is Key: Avoiding Penalties

Conclusion

Terms of Service

Privacy Policy

Core Modal Title